Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study Article Swipe

PDF

Hiroshi Inoue , Michiaki Umeyama , Takako Yamada , Hiroyuki Hashimoto , Akira Komoto , Masahiro Yasaka ·

YOU? · · 2019 · Open Access · · DOI: https://doi.org/10.1016/j.jjcc.2019.07.007

Related Topics

Concepts

Medicine Atrial fibrillation Apixaban Internal medicine Cardiology Clinical Practice Rivaroxaban Warfarin Physical therapy

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.jjcc.2019.07.007
PDF: http://www.journal-of-cardiology.com/article/S0914508719302230/pdf
OA Status: bronze
Cited By: 27
References: 31
Related Works: 10
OpenAlex ID: https://openalex.org/W2968402127

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W2968402127

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.jjcc.2019.07.007

Digital Object Identifier
Title: Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2019

Year of publication
Publication date: 2019-08-15

Full publication date if available
Authors: Hiroshi Inoue, Michiaki Umeyama, Takako Yamada, Hiroyuki Hashimoto, Akira Komoto, Masahiro Yasaka

List of authors in order
Landing page: https://doi.org/10.1016/j.jjcc.2019.07.007

Publisher landing page
PDF URL: https://www.journal-of-cardiology.com/article/S0914508719302230/pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://www.journal-of-cardiology.com/article/S0914508719302230/pdf

Direct OA link when available
Concepts: Medicine, Atrial fibrillation, Apixaban, Internal medicine, Cardiology, Clinical Practice, Rivaroxaban, Warfarin, Physical therapy

Top concepts (fields/topics) attached by OpenAlex
Cited by: 27

Total citation count in OpenAlex
Citations by year (recent): 2025: 2, 2024: 5, 2023: 3, 2021: 9, 2020: 8

Per-year citation counts (last 5 years)
References (count): 31

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W2968402127
doi	https://doi.org/10.1016/j.jjcc.2019.07.007
ids.doi	https://doi.org/10.1016/j.jjcc.2019.07.007
ids.mag	2968402127
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/31421933
ids.openalex	https://openalex.org/W2968402127
fwci	3.19660919
mesh[0].qualifier_ui
mesh[0].descriptor_ui	D000368
mesh[0].is_major_topic	False
mesh[0].qualifier_name
mesh[0].descriptor_name	Aged
mesh[1].qualifier_ui
mesh[1].descriptor_ui	D000369
mesh[1].is_major_topic	False
mesh[1].qualifier_name
mesh[1].descriptor_name	Aged, 80 and over
mesh[2].qualifier_ui	Q000008
mesh[2].descriptor_ui	D000925
mesh[2].is_major_topic	False
mesh[2].qualifier_name	administration & dosage
mesh[2].descriptor_name	Anticoagulants
mesh[3].qualifier_ui	Q000009
mesh[3].descriptor_ui	D000925
mesh[3].is_major_topic	False
mesh[3].qualifier_name	adverse effects
mesh[3].descriptor_name	Anticoagulants
mesh[4].qualifier_ui
mesh[4].descriptor_ui	D044466
mesh[4].is_major_topic	False
mesh[4].qualifier_name
mesh[4].descriptor_name	Asian People
mesh[5].qualifier_ui	Q000188
mesh[5].descriptor_ui	D001281
mesh[5].is_major_topic	False
mesh[5].qualifier_name	drug therapy
mesh[5].descriptor_name	Atrial Fibrillation
mesh[6].qualifier_ui
mesh[6].descriptor_ui	D005260
mesh[6].is_major_topic	False
mesh[6].qualifier_name
mesh[6].descriptor_name	Female
mesh[7].qualifier_ui	Q000139
mesh[7].descriptor_ui	D006470
mesh[7].is_major_topic	False
mesh[7].qualifier_name	chemically induced
mesh[7].descriptor_name	Hemorrhage
mesh[8].qualifier_ui
mesh[8].descriptor_ui	D006801
mesh[8].is_major_topic	False
mesh[8].qualifier_name
mesh[8].descriptor_name	Humans
mesh[9].qualifier_ui
mesh[9].descriptor_ui	D008297
mesh[9].is_major_topic	False
mesh[9].qualifier_name
mesh[9].descriptor_name	Male
mesh[10].qualifier_ui	Q000008
mesh[10].descriptor_ui	D011720
mesh[10].is_major_topic	False
mesh[10].qualifier_name	administration & dosage
mesh[10].descriptor_name	Pyrazoles
mesh[11].qualifier_ui	Q000009
mesh[11].descriptor_ui	D011720
mesh[11].is_major_topic	False
mesh[11].qualifier_name	adverse effects
mesh[11].descriptor_name	Pyrazoles
mesh[12].qualifier_ui	Q000008
mesh[12].descriptor_ui	D011728
mesh[12].is_major_topic	False
mesh[12].qualifier_name	administration & dosage
mesh[12].descriptor_name	Pyridones
mesh[13].qualifier_ui	Q000009
mesh[13].descriptor_ui	D011728
mesh[13].is_major_topic	False
mesh[13].qualifier_name	adverse effects
mesh[13].descriptor_name	Pyridones
mesh[14].qualifier_ui	Q000517
mesh[14].descriptor_ui	D013923
mesh[14].is_major_topic	False
mesh[14].qualifier_name	prevention & control
mesh[14].descriptor_name	Thromboembolism
mesh[15].qualifier_ui
mesh[15].descriptor_ui	D016896
mesh[15].is_major_topic	False
mesh[15].qualifier_name
mesh[15].descriptor_name	Treatment Outcome
mesh[16].qualifier_ui
mesh[16].descriptor_ui	D000368
mesh[16].is_major_topic	False
mesh[16].qualifier_name
mesh[16].descriptor_name	Aged
mesh[17].qualifier_ui
mesh[17].descriptor_ui	D000369
mesh[17].is_major_topic	False
mesh[17].qualifier_name
mesh[17].descriptor_name	Aged, 80 and over
mesh[18].qualifier_ui	Q000008
mesh[18].descriptor_ui	D000925
mesh[18].is_major_topic	False
mesh[18].qualifier_name	administration & dosage
mesh[18].descriptor_name	Anticoagulants
mesh[19].qualifier_ui	Q000009
mesh[19].descriptor_ui	D000925
mesh[19].is_major_topic	False
mesh[19].qualifier_name	adverse effects
mesh[19].descriptor_name	Anticoagulants
mesh[20].qualifier_ui
mesh[20].descriptor_ui	D044466
mesh[20].is_major_topic	False
mesh[20].qualifier_name
mesh[20].descriptor_name	Asian People
mesh[21].qualifier_ui	Q000188
mesh[21].descriptor_ui	D001281
mesh[21].is_major_topic	False
mesh[21].qualifier_name	drug therapy
mesh[21].descriptor_name	Atrial Fibrillation
mesh[22].qualifier_ui
mesh[22].descriptor_ui	D005260
mesh[22].is_major_topic	False
mesh[22].qualifier_name
mesh[22].descriptor_name	Female
mesh[23].qualifier_ui	Q000139
mesh[23].descriptor_ui	D006470
mesh[23].is_major_topic	False
mesh[23].qualifier_name	chemically induced
mesh[23].descriptor_name	Hemorrhage
mesh[24].qualifier_ui
mesh[24].descriptor_ui	D006801
mesh[24].is_major_topic	False
mesh[24].qualifier_name
mesh[24].descriptor_name	Humans
mesh[25].qualifier_ui
mesh[25].descriptor_ui	D008297
mesh[25].is_major_topic	False
mesh[25].qualifier_name
mesh[25].descriptor_name	Male
mesh[26].qualifier_ui	Q000008
mesh[26].descriptor_ui	D011720
mesh[26].is_major_topic	False
mesh[26].qualifier_name	administration & dosage
mesh[26].descriptor_name	Pyrazoles
mesh[27].qualifier_ui	Q000009
mesh[27].descriptor_ui	D011720
mesh[27].is_major_topic	False
mesh[27].qualifier_name	adverse effects
mesh[27].descriptor_name	Pyrazoles
mesh[28].qualifier_ui	Q000008
mesh[28].descriptor_ui	D011728
mesh[28].is_major_topic	False
mesh[28].qualifier_name	administration & dosage
mesh[28].descriptor_name	Pyridones
mesh[29].qualifier_ui	Q000009
mesh[29].descriptor_ui	D011728
mesh[29].is_major_topic	False
mesh[29].qualifier_name	adverse effects
mesh[29].descriptor_name	Pyridones
mesh[30].qualifier_ui	Q000517
mesh[30].descriptor_ui	D013923
mesh[30].is_major_topic	False
mesh[30].qualifier_name	prevention & control
mesh[30].descriptor_name	Thromboembolism
mesh[31].qualifier_ui
mesh[31].descriptor_ui	D016896
mesh[31].is_major_topic	False
mesh[31].qualifier_name
mesh[31].descriptor_name	Treatment Outcome
type	article
title	Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study
biblio.issue	2
biblio.volume	75
biblio.last_page	215
biblio.first_page	208
topics[0].id	https://openalex.org/T10065
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	1.0
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2705
topics[0].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[0].display_name	Atrial Fibrillation Management and Outcomes
topics[1].id	https://openalex.org/T11217
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9991999864578247
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2705
topics[1].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[1].display_name	Cardiac Arrhythmias and Treatments
topics[2].id	https://openalex.org/T10217
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9954000115394592
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2705
topics[2].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[2].display_name	Cardiac electrophysiology and arrhythmias
funders[0].id	https://openalex.org/F4320307115
funders[0].ror	https://ror.org/00gtmwv55
funders[0].display_name	Bristol-Myers Squibb
funders[1].id	https://openalex.org/F4320307765
funders[1].ror	https://ror.org/01xdqrp08
funders[1].display_name	Pfizer
is_xpac	False
apc_list.value	3000
apc_list.currency	USD
apc_list.value_usd	3000
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9182267785072327
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2779161974
concepts[1].level	2
concepts[1].score	0.8492979407310486
concepts[1].wikidata	https://www.wikidata.org/wiki/Q815819
concepts[1].display_name	Atrial fibrillation
concepts[2].id	https://openalex.org/C2780638905
concepts[2].level	5
concepts[2].score	0.842024564743042
concepts[2].wikidata	https://www.wikidata.org/wiki/Q414462
concepts[2].display_name	Apixaban
concepts[3].id	https://openalex.org/C126322002
concepts[3].level	1
concepts[3].score	0.7299489974975586
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[3].display_name	Internal medicine
concepts[4].id	https://openalex.org/C164705383
concepts[4].level	1
concepts[4].score	0.7267084717750549
concepts[4].wikidata	https://www.wikidata.org/wiki/Q10379
concepts[4].display_name	Cardiology
concepts[5].id	https://openalex.org/C2779974597
concepts[5].level	2
concepts[5].score	0.5780693292617798
concepts[5].wikidata	https://www.wikidata.org/wiki/Q28448986
concepts[5].display_name	Clinical Practice
concepts[6].id	https://openalex.org/C2778661090
concepts[6].level	4
concepts[6].score	0.1765458583831787
concepts[6].wikidata	https://www.wikidata.org/wiki/Q420262
concepts[6].display_name	Rivaroxaban
concepts[7].id	https://openalex.org/C2776301958
concepts[7].level	3
concepts[7].score	0.16494697332382202
concepts[7].wikidata	https://www.wikidata.org/wiki/Q407431
concepts[7].display_name	Warfarin
concepts[8].id	https://openalex.org/C1862650
concepts[8].level	1
concepts[8].score	0.08327138423919678
concepts[8].wikidata	https://www.wikidata.org/wiki/Q186005
concepts[8].display_name	Physical therapy
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9182267785072327
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/atrial-fibrillation
keywords[1].score	0.8492979407310486
keywords[1].display_name	Atrial fibrillation
keywords[2].id	https://openalex.org/keywords/apixaban
keywords[2].score	0.842024564743042
keywords[2].display_name	Apixaban
keywords[3].id	https://openalex.org/keywords/internal-medicine
keywords[3].score	0.7299489974975586
keywords[3].display_name	Internal medicine
keywords[4].id	https://openalex.org/keywords/cardiology
keywords[4].score	0.7267084717750549
keywords[4].display_name	Cardiology
keywords[5].id	https://openalex.org/keywords/clinical-practice
keywords[5].score	0.5780693292617798
keywords[5].display_name	Clinical Practice
keywords[6].id	https://openalex.org/keywords/rivaroxaban
keywords[6].score	0.1765458583831787
keywords[6].display_name	Rivaroxaban
keywords[7].id	https://openalex.org/keywords/warfarin
keywords[7].score	0.16494697332382202
keywords[7].display_name	Warfarin
keywords[8].id	https://openalex.org/keywords/physical-therapy
keywords[8].score	0.08327138423919678
keywords[8].display_name	Physical therapy
language	en
locations[0].id	doi:10.1016/j.jjcc.2019.07.007
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S76729639
locations[0].source.issn	0914-5087, 1876-4738
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0914-5087
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Journal of Cardiology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].source.host_organization_lineage_names	Elsevier BV
locations[0].license
locations[0].pdf_url	http://www.journal-of-cardiology.com/article/S0914508719302230/pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Journal of Cardiology
locations[0].landing_page_url	https://doi.org/10.1016/j.jjcc.2019.07.007
locations[1].id	pmid:31421933
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Journal of cardiology
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/31421933
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5102894501
authorships[0].author.orcid	https://orcid.org/0000-0002-0775-8936
authorships[0].author.display_name	Hiroshi Inoue
authorships[0].countries	JP
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210143192
authorships[0].affiliations[0].raw_affiliation_string	Saiseikai Toyama Hospital, Toyama, Japan
authorships[0].institutions[0].id	https://openalex.org/I4210143192
authorships[0].institutions[0].ror	https://ror.org/04a2npp96
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I4210143192
authorships[0].institutions[0].country_code	JP
authorships[0].institutions[0].display_name	Toyama University Hospital
authorships[0].author_position	first
authorships[0].raw_author_name	Hiroshi Inoue
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Saiseikai Toyama Hospital, Toyama, Japan
authorships[1].author.id	https://openalex.org/A5079773425
authorships[1].author.orcid
authorships[1].author.display_name	Michiaki Umeyama
authorships[1].countries	JP
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210148404
authorships[1].affiliations[0].raw_affiliation_string	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[1].institutions[0].id	https://openalex.org/I4210148404
authorships[1].institutions[0].ror	https://ror.org/04dbmrm19
authorships[1].institutions[0].type	company
authorships[1].institutions[0].lineage	https://openalex.org/I4210091812, https://openalex.org/I4210148404
authorships[1].institutions[0].country_code	JP
authorships[1].institutions[0].display_name	Bristol-Myers Squibb (Japan)
authorships[1].author_position	middle
authorships[1].raw_author_name	Michiaki Umeyama
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[2].author.id	https://openalex.org/A5013684848
authorships[2].author.orcid
authorships[2].author.display_name	Takako Yamada
authorships[2].countries	JP
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210148404
authorships[2].affiliations[0].raw_affiliation_string	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[2].institutions[0].id	https://openalex.org/I4210148404
authorships[2].institutions[0].ror	https://ror.org/04dbmrm19
authorships[2].institutions[0].type	company
authorships[2].institutions[0].lineage	https://openalex.org/I4210091812, https://openalex.org/I4210148404
authorships[2].institutions[0].country_code	JP
authorships[2].institutions[0].display_name	Bristol-Myers Squibb (Japan)
authorships[2].author_position	middle
authorships[2].raw_author_name	Takako Yamada
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[3].author.id	https://openalex.org/A5035784645
authorships[3].author.orcid	https://orcid.org/0000-0001-6912-6953
authorships[3].author.display_name	Hiroyuki Hashimoto
authorships[3].countries	JP
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210148786
authorships[3].affiliations[0].raw_affiliation_string	Pfizer Japan Inc., Tokyo, Japan
authorships[3].institutions[0].id	https://openalex.org/I4210148786
authorships[3].institutions[0].ror	https://ror.org/05pm71w80
authorships[3].institutions[0].type	company
authorships[3].institutions[0].lineage	https://openalex.org/I180857899, https://openalex.org/I4210148786
authorships[3].institutions[0].country_code	JP
authorships[3].institutions[0].display_name	Pfizer (Japan)
authorships[3].author_position	middle
authorships[3].raw_author_name	Hiroyuki Hashimoto
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Pfizer Japan Inc., Tokyo, Japan
authorships[4].author.id	https://openalex.org/A5066970622
authorships[4].author.orcid
authorships[4].author.display_name	Akira Komoto
authorships[4].countries	JP
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210148404
authorships[4].affiliations[0].raw_affiliation_string	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[4].institutions[0].id	https://openalex.org/I4210148404
authorships[4].institutions[0].ror	https://ror.org/04dbmrm19
authorships[4].institutions[0].type	company
authorships[4].institutions[0].lineage	https://openalex.org/I4210091812, https://openalex.org/I4210148404
authorships[4].institutions[0].country_code	JP
authorships[4].institutions[0].display_name	Bristol-Myers Squibb (Japan)
authorships[4].author_position	middle
authorships[4].raw_author_name	Akira Komoto
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Bristol-Myers Squibb K.K., Tokyo, Japan
authorships[5].author.id	https://openalex.org/A5015689408
authorships[5].author.orcid	https://orcid.org/0000-0002-1163-8355
authorships[5].author.display_name	Masahiro Yasaka
authorships[5].countries	JP
authorships[5].affiliations[0].institution_ids	https://openalex.org/I3018397740
authorships[5].affiliations[0].raw_affiliation_string	National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
authorships[5].institutions[0].id	https://openalex.org/I3018397740
authorships[5].institutions[0].ror	https://ror.org/022296476
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I3018397740, https://openalex.org/I4210137409
authorships[5].institutions[0].country_code	JP
authorships[5].institutions[0].display_name	National Kyushu Medical Center
authorships[5].author_position	last
authorships[5].raw_author_name	Masahiro Yasaka
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	http://www.journal-of-cardiology.com/article/S0914508719302230/pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10065
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	1.0
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2705
primary_topic.subfield.display_name	Cardiology and Cardiovascular Medicine
primary_topic.display_name	Atrial Fibrillation Management and Outcomes
related_works	https://openalex.org/W4387497383, https://openalex.org/W3183948672, https://openalex.org/W3173606202, https://openalex.org/W3110381201, https://openalex.org/W2948807893, https://openalex.org/W2935909890, https://openalex.org/W2899084033, https://openalex.org/W2778153218, https://openalex.org/W2758277628, https://openalex.org/W1531601525
cited_by_count	27
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	2
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	5
counts_by_year[2].year	2023
counts_by_year[2].cited_by_count	3
counts_by_year[3].year	2021
counts_by_year[3].cited_by_count	9
counts_by_year[4].year	2020
counts_by_year[4].cited_by_count	8
locations_count	2
best_oa_location.id	doi:10.1016/j.jjcc.2019.07.007
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S76729639
best_oa_location.source.issn	0914-5087, 1876-4738
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0914-5087
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Journal of Cardiology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.source.host_organization_lineage_names	Elsevier BV
best_oa_location.license
best_oa_location.pdf_url	http://www.journal-of-cardiology.com/article/S0914508719302230/pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Journal of Cardiology
best_oa_location.landing_page_url	https://doi.org/10.1016/j.jjcc.2019.07.007
primary_location.id	doi:10.1016/j.jjcc.2019.07.007
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S76729639
primary_location.source.issn	0914-5087, 1876-4738
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0914-5087
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Journal of Cardiology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.source.host_organization_lineage_names	Elsevier BV
primary_location.license
primary_location.pdf_url	http://www.journal-of-cardiology.com/article/S0914508719302230/pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Journal of Cardiology
primary_location.landing_page_url	https://doi.org/10.1016/j.jjcc.2019.07.007
publication_date	2019-08-15
publication_year	2019
referenced_works	https://openalex.org/W2162508946, https://openalex.org/W2313548138, https://openalex.org/W2606124883, https://openalex.org/W2569205071, https://openalex.org/W2804825316, https://openalex.org/W2795780459, https://openalex.org/W2750856436, https://openalex.org/W2785163084, https://openalex.org/W2784740969, https://openalex.org/W2768642390, https://openalex.org/W2733913781, https://openalex.org/W2944592714, https://openalex.org/W1550111394, https://openalex.org/W2127985968, https://openalex.org/W2162586165, https://openalex.org/W2433454023, https://openalex.org/W2790375504, https://openalex.org/W2102255195, https://openalex.org/W4236921231, https://openalex.org/W2786585951, https://openalex.org/W2485673570, https://openalex.org/W2887410593, https://openalex.org/W2913595217, https://openalex.org/W1986949270, https://openalex.org/W2345536851, https://openalex.org/W2128009777, https://openalex.org/W2899332619, https://openalex.org/W2774842899, https://openalex.org/W3177911404, https://openalex.org/W2914840161, https://openalex.org/W3201435656
referenced_works_count	31
abstract_inverted_index
cited_by_percentile_year.max	99
cited_by_percentile_year.min	95
corresponding_author_ids	https://openalex.org/A5102894501
countries_distinct_count	1
institutions_distinct_count	6
corresponding_institution_ids	https://openalex.org/I4210143192
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.8100000023841858
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.91638533
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	True